Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Overview
Radiotherapy and Oncology is a renowned scientific journal published by the European Society for Therapeutic Radiology and Oncology. It focuses on the latest advancements and research in the field of radiation therapy and oncology. The journal covers a wide range of topics including clinical trials, treatment techniques, radiation biology, and imaging. It serves as a valuable resource for healthcare professionals, researchers, and students interested in the field of cancer treatment and radiation therapy.
Details
Details
Metrics
Metrics
h-index / Ranks: 904
182
SJR / Ranks: 1569
1702
CiteScore / Ranks: 1286
10.50
JIF / Ranks: 1231
5.7
Recent Articles
1.
Lalmahomed T, Willigenburg T, van de Pol S, de Groot-van Breugel E, Snoeren L, Hes J, et al.
Radiother Oncol
. 2025 Mar;
:110845.
PMID: 40089162
Background And Purpose: A sub-fractionation workflow to correct for intrafraction motion in localized prostate cancer radiotherapy was implemented at our center, allowing for PTV margin reduction from isotropic 5 mm...
2.
Kristensen M, Nielsen S, Alsner J, Sander Holm A, Hansen C, Overgaard J, et al.
Radiother Oncol
. 2025 Mar;
:110838.
PMID: 40089161
Background And Purpose: The prognosis following loco-regional failure after primary radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC) is poor. The hypothesis that most failures occur as a...
3.
Bogaerts E, Saade G, Macaeva E, Chiavassa S, Evin M, Haddad F, et al.
Radiother Oncol
. 2025 Mar;
:110848.
PMID: 40086473
Background And Purpose: Ultra-high dose rate (UHDR) irradiation induces less normal tissues toxicities compared to conventional dose rate (CONV) irradiation. We aimed to assess whether UHDR and CONV proton irradiation...
4.
Rahman S, Patel P, Finkelstein S, Lee S, Wong H, Chan A, et al.
Radiother Oncol
. 2025 Mar;
:110846.
PMID: 40086472
Introduction: Acute radiation dermatitis (ARD) is a common side effect experienced during radiation therapy (RT) for cancer. Published clinical trials for ARD use a myriad of assessment tools and outcomes...
5.
Pham T, Coupey J, Yger F, Candeias S, Thariat J, Valable S
Radiother Oncol
. 2025 Mar;
206:110801.
PMID: 40081500
Introduction: Although lymphopenia is linked to immune suppression favoring tumor growth, the effect of different radiation types on specific T-lymphocyte subsets remains unclear. Among the T-lymphocyte subpopulations, CD8-lymphocytes serve as...
6.
April Chau O, Geoghegan T, Everts J, Chen J, Feng M, Chen W, et al.
Radiother Oncol
. 2025 Mar;
206:110839.
PMID: 40081499
Background: Liver tumors have low contrast on 4DCT. A novel Multitasking (MT)MR imaging technique has been implemented on the MR simulator, providing both T1 and T2-weighted 4DMR images in a...
7.
B M S, Sugden B, Witlox W, W J A W, Ramaekers B, B R, et al.
Radiother Oncol
. 2025 Mar;
:110832.
PMID: 40058706
Background/purpose: Proton radiation-therapy (PrT) may provide clinical benefit for lung cancer compared to photon radiation-therapy (PhT), however is more costly. Literature reporting costs for PrT, PhT, and comparisons thereof, particularly...
8.
9.
10.
Caluwe A, Bellal S, Cao K, Peignaux K, Remouchamps V, Baten A, et al.
Radiother Oncol
. 2025 Mar;
206:110836.
PMID: 40057199
Background And Purpose: The randomized multicentric phase II Neo-CheckRay trial investigated preoperative immune-modulating stereotactic body radiation therapy (iSBRT) 8 Gy x 3 fractions in combination with chemotherapy with or without...